Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dynavax Technologies Corp | 12,526,486 | 17,791,486 | +5,265,000 | $139.55M | $227.20M | 8.52% | +$87.65M |
| Guardant Health, Inc.(GH) | 6,000,560 | 6,419,566 | +419,006 | $137.65M | $196.12M | 7.35% | +$58.46M |
| Intra-Cellular Therapies Inc | 1,600,693 | 2,000,000 | +399,307 | $117.12M | $167.04M | 6.26% | +$49.92M |
| Immunovant, Inc.(IMVT) | 4,347,464 | 6,000,000 | +1,652,536 | $123.95M | $148.62M | 5.57% | +$24.67M |
| Apellis Pharmaceuticals Inc COM | 4,400,654 | 4,274,921 | -125,733 | $126.91M | $136.41M | 5.11% | +$9.50M |
| Springworks Therapeutics Inc | 3,843,900 | 3,460,756 | -383,144 | $123.16M | $125.04M | 4.69% | +$1.88M |
| Cytokinetics, Incorporated(CYTK) | 629,906 | 2,500,000 | +1,870,094 | $33.26M | $117.60M | 4.41% | +$84.34M |
| Ocular Therapeutix, Inc.(OCUL) | 12,721,460 | 12,836,282 | +114,822 | $110.68M | $109.62M | 4.11% | -$1.05M |
| Viridian Therapeutics, Inc.(VRDN) | 3,750,945 | 4,522,741 | +771,796 | $85.33M | $86.70M | 3.25% | +$1.37M |
| Pliant Therapeutics, Inc.(PLRX) | 5,972,257 | 5,972,257 | 0 | $66.95M | $78.65M | 2.95% | +$11.71M |
| Structure Therapeutics IncADS | 1,220,508 | 2,800,000 | +1,579,492 | $53.57M | $75.94M | 2.85% | +$22.37M |
| Ionis Pharmaceuticals, Inc.(IONS) | 2,200,000 | 1,933,928 | -266,072 | $88.13M | $67.61M | 2.53% | -$20.52M |
| Nurix Therapeutics, Inc.(NRIX) | 3,868,104 | 3,000,000 | -868,104 | $86.92M | $56.52M | 2.12% | -$30.40M |
| MBX Biosciences, Inc.(MBX) | 3,018,935 | 3,018,935 | 0 | $78.43M | $55.64M | 2.09% | -$22.79M |
| 89bio Inc | 2,766,512 | 6,478,249 | +3,711,737 | $20.47M | $50.66M | 1.90% | +$30.19M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 0 | 1,450,000 | +1,450,000 | $0 | $49.89M | 1.87% | +$49.89M |
| Dyne Therapeutics, Inc.(DYN) | 3,282,000 | 2,000,000 | -1,282,000 | $117.89M | $47.12M | 1.77% | -$70.77M |
| Septerna, Inc.(SEPN) | 0 | 1,912,929 | +1,912,929 | $0 | $43.81M | 1.64% | +$43.81M |
| Neumora Therapeutics, Inc.(NMRA) | 567,428 | 4,000,000 | +3,432,572 | $7.50M | $42.40M | 1.59% | +$34.90M |
| Genmab A/SADS(GMAB) | 0 | 2,000,000 | +2,000,000 | $0 | $41.74M | 1.56% | +$41.74M |
| Akero Therapeutics Inc | 689,784 | 1,490,000 | +800,216 | $19.79M | $41.45M | 1.55% | +$21.66M |
| Verona Pharma PlcADS | 3,180,025 | 850,000 | -2,330,025 | $91.49M | $39.47M | 1.48% | -$52.02M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 1,540,132 | +1,540,132 | $0 | $38.92M | 1.46% | +$38.92M |
| Protagonist Therapeutics Inc | 0 | 1,000,000 | +1,000,000 | $0 | $38.60M | 1.45% | +$38.60M |
| ANI Pharmaceuticals, Inc.(ANIP) | 504,828 | 649,042 | +144,214 | $30.12M | $35.88M | 1.35% | +$5.76M |
| Bicara Therapeutics Inc | 796,852 | 2,000,000 | +1,203,148 | $20.30M | $34.84M | 1.31% | +$14.54M |
| Autolus Therapeutics plcADS(AUTL) | 15,272,172 | 14,218,903 | -1,053,269 | $55.44M | $33.41M | 1.25% | -$22.02M |
| Korro Bio, Inc.(KRRO) | 850,000 | 874,614 | +24,614 | $28.41M | $33.30M | 1.25% | +$4.89M |
| Terns Pharmaceuticals Inc | 5,576,558 | 5,576,558 | 0 | $46.51M | $30.89M | 1.16% | -$15.61M |
| Engene Holdings Inc COM | 2,607,633 | 4,557,575 | +1,949,942 | $17.21M | $30.31M | 1.14% | +$13.10M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 653,513 | +653,513 | $0 | $27.49M | 1.03% | +$27.49M |
| ABIVAX Société AnonymeADS(ABVX) | 3,579,209 | 3,579,209 | 0 | $41.23M | $26.20M | 0.98% | -$15.03M |
| Centessa Pharmaceuticals PlcADS | 1,350,000 | 1,350,000 | 0 | $21.59M | $22.61M | 0.85% | +$1.03M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 819,162 | +819,162 | $0 | $22.48M | 0.84% | +$22.48M |
| Lakefront Biotherapeutics NVADR(LKFT) | 0 | 780,778 | +780,778 | $0 | $21.47M | 0.81% | +$21.47M |
| Olema Pharmaceuticals, Inc.(OLMA) | 4,000,000 | 3,442,833 | -557,167 | $47.76M | $20.07M | 0.75% | -$27.69M |
| Mind Medicine Mindmed Inc | 7,065,099 | 2,816,594 | -4,248,505 | $40.20M | $19.60M | 0.73% | -$20.60M |
| Edgewise Therapeutics, Inc.(EWTX) | 1,100,536 | 710,421 | -390,115 | $29.37M | $18.97M | 0.71% | -$10.41M |
| Bicycle Therapeutics PlcADS | 3,548,001 | 1,276,081 | -2,271,920 | $80.29M | $17.87M | 0.67% | -$62.43M |
| Upstream Bio, Inc.(UPB) | 0 | 1,000,000 | +1,000,000 | $0 | $16.44M | 0.62% | +$16.44M |
| Novavax, Inc.(NVAX) | 0 | 2,000,000 | +2,000,000 | $0 | $16.08M | 0.60% | +$16.08M |
| Immunocore Holdings plcADS(IMCR) | 0 | 519,376 | +519,376 | $0 | $15.32M | 0.57% | +$15.32M |
| Oruka Therapeutics, Inc.(ORKA) | 1,235,187 | 750,000 | -485,187 | $30.27M | $14.54M | 0.55% | -$15.73M |
| Geron Corporation(GERN) | 7,575,049 | 4,011,287 | -3,563,762 | $34.39M | $14.20M | 0.53% | -$20.19M |
| Cybin D/B/A Helus Pharma(HELP) | 1,529,987 | 1,529,987 | 0 | $13.60M | $13.49M | 0.51% | -$107.1K |
| Xencor, Inc.(XNCR) | 800,000 | 500,000 | -300,000 | $16.09M | $11.49M | 0.43% | -$4.60M |
| Aligos Therapeutics, Inc.(ALGS) | 244,110 | 244,110 | 0 | $2.11M | $9.73M | 0.36% | +$7.61M |
| Rapt Therapeutics Inc | 0 | 6,011,380 | +6,011,380 | $0 | $9.50M | 0.36% | +$9.50M |
| Zura Bio LimitedCL A(ZURA) | 3,283,783 | 3,283,783 | 0 | $13.33M | $8.21M | 0.31% | -$5.12M |
| Context Therapeutics Inc.(CNTX) | 7,419,355 | 7,419,355 | 0 | $14.54M | $7.79M | 0.29% | -$6.75M |
| Allakos Inc | 5,000,000 | 5,704,282 | +704,282 | $3.27M | $6.90M | 0.26% | +$3.64M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 169,132 | +169,132 | $0 | $6.63M | 0.25% | +$6.63M |
| Avalo Therapeutics, Inc.(AVTX) | 967,000 | 867,000 | -100,000 | $9.19M | $6.44M | 0.24% | -$2.74M |
| Inovio Pharmaceuticals, Inc.(INO) | 1,804,366 | 3,119,162 | +1,314,796 | $10.43M | $5.71M | 0.21% | -$4.72M |
| Regulus Therapeutics Inc | 3,262,564 | 3,262,564 | 0 | $5.12M | $5.15M | 0.19% | +$32.6K |
| Spyre Therapeutics, Inc.(SYRE) | 1,000,000 | 219,015 | -780,985 | $29.41M | $5.10M | 0.19% | -$24.31M |
| Invivyd, Inc.(IVVD) | 10,953,937 | 10,689,603 | -264,334 | $11.17M | $4.74M | 0.18% | -$6.44M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 523,989 | +523,989 | $0 | $4.51M | 0.17% | +$4.51M |
| 4d Molecular Therapeutics In | 4,096,452 | 609,900 | -3,486,552 | $44.28M | $3.40M | 0.13% | -$40.89M |
| Climb Bio, Inc.(CLYM) | 2,169,143 | 1,040,115 | -1,129,028 | $11.04M | $1.87M | 0.07% | -$9.17M |
| Nektar Therapeutics(NKTR) | 15,922,655 | 1,975,998 | -13,946,657 | $20.70M | $1.84M | 0.07% | -$18.86M |
| Alector Inc | 4,631,998 | 0 | -4,631,998 | $21.59M | $0 | — | -$21.59M |
| Alkermes plcSHS(ALKS) | 3,500,000 | 0 | -3,500,000 | $97.97M | $0 | — | -$97.97M |
| Alto Neuroscience, Inc.(ANRO) | 219,648 | 0 | -219,648 | $2.51M | $0 | — | -$2.51M |
| Apogee Therapeutics Inc | 1,000,000 | 0 | -1,000,000 | $58.74M | $0 | — | -$58.74M |
| argenx SEADR(ARGX) | 365,000 | 0 | -365,000 | $197.86M | $0 | — | -$197.86M |
| Avidity Biosciences Inc | 475,000 | 0 | -475,000 | $21.82M | $0 | — | -$21.82M |
| Axsome Therapeutics, Inc.(AXSM) | 857,219 | 0 | -857,219 | $77.04M | $0 | — | -$77.04M |
| Editas Medicine, Inc.(EDIT) | 4,900,334 | 0 | -4,900,334 | $16.71M | $0 | — | -$16.71M |
| Fate Therapeutics, Inc.(FATE) | 5,572,607 | 0 | -5,572,607 | $19.50M | $0 | — | -$19.50M |
| Intellia Therapeutics, Inc.(NTLA) | 4,950,000 | 0 | -4,950,000 | $101.72M | $0 | — | -$101.72M |
| Kura Oncology, Inc.(KURA) | 1,963,505 | 0 | -1,963,505 | $38.37M | $0 | — | -$38.37M |
| Kymera Therapeutics, Inc.(KYMR) | 600,326 | 0 | -600,326 | $28.41M | $0 | — | -$28.41M |
| Metagenomi Therapeutics, Inc.(MGX) | 307,500 | 0 | -307,500 | $667.3K | $0 | — | -$667.3K |
| Prothena Corp PlcSHS SHS | 140,000 | 0 | -140,000 | $2.34M | $0 | — | -$2.34M |
| Pyxis Oncology, Inc.(PYXS) | 4,184,100 | 0 | -4,184,100 | $15.36M | $0 | — | -$15.36M |
| Relmada Therapeutics, Inc.(RLMD) | 674,833 | 0 | -674,833 | $2.19M | $0 | — | -$2.19M |
| Scholar Rock Holding Corporation(SRRK) | 48,100 | 0 | -48,100 | $385.3K | $0 | — | -$385.3K |
| Silence Therapeutics plcADS(SLN) | 1,000,000 | 0 | -1,000,000 | $18.18M | $0 | — | -$18.18M |
| Syros Pharmaceuticals Inc | 828,485 | 0 | -828,485 | $1.78M | $0 | — | -$1.78M |
| TG Therapeutics, Inc.(TGTX) | 1,725,000 | 0 | -1,725,000 | $40.35M | $0 | — | -$40.35M |
| Travere Therapeutics, Inc.(TVTX) | 531,857 | 0 | -531,857 | $7.44M | $0 | — | -$7.44M |
| Vigil Neuroscience Inc | 1,553,996 | 0 | -1,553,996 | $5.28M | $0 | — | -$5.28M |